This workflow further enables the discovery of altered GSL metabolism in human glioma tissue samples and the phenotyping of gliomas with isocitrate dehydrogenase genetic mutations (IDH-mutant), gliomas without IDH mutations (IDH-wildtype), and normal brain tissue samples. The gene discussed is IDH3A; the disease is central nervous system cancer.